This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Harvard College. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations of James Dicarlo in Genome Engineering
Introduction
James Dicarlo is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of genome engineering, particularly through his innovative patent related to RNA-guided methods.
Latest Patents
Dicarlo holds a patent for "Multiplex RNA-guided genome engineering." This patent outlines methods of multiplex genome engineering in cells using Cas9. The process involves introducing a first foreign nucleic acid encoding one or more RNAs that are complementary to the target DNA. These RNAs guide the enzyme to the target DNA, forming a co-localization complex. Additionally, a second foreign nucleic acid encoding donor nucleic acid sequences is introduced, allowing the cycle to be repeated multiple times for effective multiplex DNA engineering in cells. He has 1 patent to his name.
Career Highlights
James Dicarlo is affiliated with Harvard College, where he continues to advance research in genome engineering. His work has garnered attention for its potential applications in various fields, including medicine and biotechnology.
Collaborations
Dicarlo collaborates with notable figures in the scientific community, including George M. Church, enhancing the impact of his research through shared expertise and resources.
Conclusion
James Dicarlo's innovative work in genome engineering exemplifies the potential of modern science to transform genetic research and applications. His contributions are paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
